The Cationic Cytokine IL-26 Differentially Modulates Virus Infection in Culture

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Braum, Oliver ^a   Klages, Michael ^a   Fickenscher, Helmut ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 26; INTERLEUKIN 26 ANTIBODY; INTERLEUKIN 26 RECEPTOR; INTERLEUKIN RECEPTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MICROFLUOROMETRY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VESICULAR STOMATITIS VIRUS; VIRUS ATTACHMENT; VIRUS CULTURE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOMEGALOVIRUS; HEK293 CELLS; HEP G2 CELLS; HERPESVIRUS 1, HUMAN; HT29 CELLS; HUMANS; INTERLEUKINS; VERO CELLS; VESICULAR STOMATITIS INDIANA VIRUS; VIRUS DISEASES;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5; VESICULAR STOMATITIS VIRUS;

EID: 84880032498     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070281     Document Type: Article

References (66)

1. Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H, (2004) The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76: 314-321. doi:10.1189/jlb.0204117. PubMed: 15123776.
2. Fickenscher H, Hör S, Küpers H, Knappe A, Wittmann S, et al. (2002) The interleukin-10 family of cytokines. Trends Immunol 23: 89-96. doi:10.1016/S1471-4906(01)02149-4. PubMed: 11929132.
3. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979. doi:10.1146/annurev.immunol.22.012703.104622. PubMed: 15032600.
4. Renauld JC, (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 3: 667-676. doi:10.1038/nri1153. PubMed: 12974481.
5. Braum O, Pirzer H, Fickenscher H, (2006) Interleukin-26, an epitheliotropic T-cell cytokine. Antiinflamm Antiallergy Agents Med Chem 5: 275-277.
6. Braum O, Pirzer H, Fickenscher H, (2007) Interleukin-26, a T-cellular activator of epithelial cells. In: Zdanov A, eds. Class II Cytokines 2007. Trivandrum: Transworld Research Network. pp. pp. 193-200.
7. Braum O, Pirzer H, Fickenscher H, (2012) Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells. Antiinflamm Antiallergy Agents Med Chem 11: 221-229. PubMed: 23106140.
8. Donnelly RP, Sheikh F, Dickensheets H, Savan R, Young HA, et al. (2010) Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev 21: 393-401. doi:10.1016/j.cytogfr.2010.09.001. PubMed: 20947410.
9. Fickenscher H, Pirzer H, (2004) Interleukin-26. Int Immunopharmacol 4: 609-613. doi:10.1016/j.intimp.2004.01.004. PubMed: 15120646.
10. Knappe A, Hör S, Wittmann S, Fickenscher H, (2000) Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus Saimiri. J Virol 74: 3881-3887. doi:10.1128/JVI.74.8.3881-3887.2000. PubMed: 10729163.
11. Collins PL, Henderson MA, Aune TM, (2012) Lineage-specific adjacent IFNG and IL26 genes share a common distal enhancer element. Genes Immun 13: 481-488. doi:10.1038/gene.2012.22. PubMed: 22622197.
12. Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC, (2000) IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1: 488-494. doi:10.1038/sj.gene.6363716. PubMed: 11197690.
13. Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R, (2004) Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 4: 577-592. doi:10.1016/j.intimp.2004.01.007. PubMed: 15120644.
14. Wolk K, Kunz S, Asadullah K, Sabat R, (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168: 5397-5402. PubMed: 12023331.
15. Hör S, Pirzer H, Dumoutier L, Bauer F, Wittmann S, et al. (2004) The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J Biol Chem 279: 33343-33351. doi:10.1074/jbc.M405000200. PubMed: 15178681.
16. Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S, et al. (2012) IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLOS Biol 10: e1001395. PubMed: 23055831.
17. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957. doi:10.1038/nrg2199. PubMed: 17676044.
18. Esendagli G, Kurne AT, Sayat G, Kilic AK, Guc D, et al. (2013) Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon β-1 therapy. J Neuroimmunol 255: 81-84. doi:10.1016/j.jneuroim.2012.10.009. PubMed: 23177721.
19. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725. doi:10.1038/nature07537. PubMed: 18978771.
20. Hughes T, Becknell B, McClory S, Briercheck E, Freud AG, et al. (2009) Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113: 4008-4010. doi:10.1182/blood-2008-12-192443. PubMed: 19244159.
21. Chang C, Magracheva E, Kozlov S, Fong S, Tobin G, et al. (2003) Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem 278: 3308-3313. doi:10.1074/jbc.M208602200. PubMed: 12403790.
22. Nagem RA, Colau D, Dumoutier L, Renauld JC, Ogata C, et al. (2002) Crystal structure of recombinant human interleukin-22. Structure 10: 1051-1062. doi:10.1016/S0969-2126(02)00797-9. PubMed: 12176383.
23. Trivella DB, Ferreira-Júnior JR, Dumoutier L, Renauld JC, Polikarpov I, (2010) Structure and function of interleukin-22 and other members of the interleukin-10 family. Cell Mol Life Sci 67: 2909-2935. doi:10.1007/s00018-010-0380-0. PubMed: 20454917.
24. Xu T, Logsdon NJ, Walter MR, (2005) Structure of insect-cell-derived IL-22. Acta Crystallogr D Biol Crystallogr 61: 942-950. doi:10.1107/S1744309105029222. PubMed: 15983417.
25. Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J, et al. (1995) Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure 3: 591-601. doi:10.1016/S0969-2126(01)00193-9. PubMed: 8590020.
26. Zdanov A, Schalk-Hihi C, Wlodawer A, (1996) Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor. Protein Sci 5: 1955-1962. doi:10.1002/pro.5560051001. PubMed: 8897595.
27. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC, (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 3545-3529. PubMed: 11564763.
28. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, (2002) Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 277: 47517-47523. doi:10.1074/jbc.M205114200. PubMed: 12351624.
29. Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, et al. (2004) Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 172: 2006-2010. PubMed: 14764663.
30. Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR, (2006) Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem 281: 35088-35096. doi:10.1074/jbc.M606791200. PubMed: 16982608.
31. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, et al. (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104: 9-19. doi:10.1016/S0092-8674(01)00187-8. PubMed: 11163236.
32. Sa SM, Valdez PA, Wu J, Jung K, Zhong F, et al. (2007) The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178: 2229-2240. PubMed: 17277128.
33. Wolk K, Witte K, Witte E, Proesch S, Schulze-Tanzil G, et al. (2008) Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol 83: 1181-1193. doi:10.1189/jlb.0807525. PubMed: 18281438.
34. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, et al. (2009) The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58: 1207-1217. doi:10.1136/gut.2007.130112. PubMed: 18483078.
35. Goris A, Heggarty S, Marrosu MG, Graham C, Billiau A, et al. (2002) Linkage disequilibrium analysis of chromosome 12q14-15 in multiple sclerosis: delineation of a 118-kb interval around interferon-gamma (IFNG) that is involved in male versus female differential susceptibility. Genes Immun 3: 470-476. doi:10.1038/sj.gene.6363913. PubMed: 12486605.
36. Goris A, Marrosu MG, Vandenbroeck K, (2001) Novel polymorphisms in the IL-10 related AK155 gene (chromosome 12q15). Genes Immun 2: 284-286. doi:10.1038/sj.gene.6363772. PubMed: 11528524.
37. Vandenbroeck K, Cunningham S, Goris A, Alloza I, Heggarty S, et al. (2003) Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis. Arthritis Rheum 48: 2773-2778. doi:10.1002/art.11236. PubMed: 14558082.
38. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220. doi:10.1038/ng.275. PubMed: 19122664.
39. Manel N, Unutmaz D, Littman DR, (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9: 641-649. doi:10.1038/ni.1610. PubMed: 18454151.
40. Sedwick C, (2012) IL-26 kick-starts rheumatoid arthritis. PLOS Biol 10: e1001398. PubMed: 23049483.
41. Dumoutier L, Lejeune D, Hör S, Fickenscher H, Renauld JC, (2003) Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT) 1. Stat 2 and STAT3. Biochem J 370: 391-396.
42. Kotenko SV, (2011) IFN-λs. Curr Opin Immunol 23: 583-590. doi:10.1016/j.coi.2011.07.007. PubMed: 21840693.
43. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77. doi:10.1038/nrm1003. PubMed: 12483210.
44. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68. doi:10.1038/ni873. PubMed: 12469119.
45. Witte K, Witte E, Sabat R, Wolk K, (2010) IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 21: 237-251. doi:10.1016/j.cytogfr.2010.04.002. PubMed: 20655797.
46. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, et al. (2006) Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44: 896-906. doi:10.1002/hep.21312. PubMed: 17006906.
47. Boritz E, Gerlach J, Johnson JE, Rose JK, (1999) Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J Virol 73: 6937-6945. PubMed: 10400792.
48. Dalton KP, Rose JK, (2001) Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279: 414-421. doi:10.1006/viro.2000.0736. PubMed: 11162797.
49. Marschall M, Freitag M, Weiler S, Sorg G, Stamminger T, (2000) Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother 44: 1588-1597. doi:10.1128/AAC.44.6.1588-1597.2000. PubMed: 10817714.
50. Arthur JL, Scarpini CG, Connor V, Lachmann RH, Tolkovsky AM, (2001) Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J Virol 75: 3885-3895. doi:10.1128/JVI.75.8.3885-3895.2001. PubMed: 11264377.
51. Friedrich M, Holzmann R, Sterry W, Wolk K, Truppel A, et al. (2003) Ultraviolet B radiation-mediated inhibition of interferon-gamma-induced keratinocyte activation is independent of interleukin-10 and other soluble mediators but associated with enhanced intracellular suppressors of cytokine-signaling expression. J Invest Dermatol 121: 845-852. doi:10.1046/j.1523-1747.2003.12482.x. PubMed: 14632204.
52. Janssens N, Janicot M, Perera T, Bakker A, (2004) Housekeeping genes as internal standards in cancer research. Mol Diagn 8: 107-113. doi:10.2165/00066982-200408020-00005. PubMed: 15527325.
53. Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, et al. (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6: 821-825. doi:10.1038/77558. PubMed: 10888934.
54. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, et al. (2005) IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 289: G960-G968. doi:10.1152/ajpgi.00126.2005. PubMed: 16051921.
55. Dambacher J, Beigel F, Zitzmann K, Heeg MH, Göke B, et al. (2008) The role of interleukin-22 in hepatitis C virus infection. Cytokine 41: 209-216. doi:10.1016/j.cyto.2007.11.016. PubMed: 18191408.
56. Lallemand C, Blanchard B, Palmieri M, Lebon P, May E, et al. (2007) Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 26: 328-338. doi:10.1038/sj.onc.1209795. PubMed: 16832344.
57. Hummelshoj L, Ryder LP, Poulsen LK, (2006) The role of the interleukin-10 subfamily members in immunoglobulin production by human B cells. Scand J Immunol 64: 40-47. doi:10.1111/j.1365-3083.2006.01773.x. PubMed: 16784489.
58. Bailey CA, Miller DK, Lenard J, (1984) Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells. Virology 133: 111-118. doi:10.1016/0042-6822(84)90429-X. PubMed: 6199890.
59. Carneiro FA, Bianconi ML, Weissmüller G, Stauffer F, Da Poian AT, (2002) Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions. J Virol 76: 3756-3764. doi:10.1128/JVI.76.8.3756-3764.2002. PubMed: 11907215.
60. Davis HE, Morgan JR, Yarmush ML, (2002) Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem 97: 159-172. doi:10.1016/S0301-4622(02)00057-1. PubMed: 12050007.
61. Davis HE, Rosinski M, Morgan JR, Yarmush ML, (2004) Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J 86: 1234-1242. doi:10.1016/S0006-3495(04)74197-1. PubMed: 14747357.
62. Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, et al. (2007) Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131: 1059-1071. doi:10.1016/j.cell.2007.10.014. PubMed: 18083097.
63. Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, et al. (2009) The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol 83: 73-80. doi:10.1128/JVI.01366-08. PubMed: 18945786.
64. Crack LR, Jones L, Malavige GN, Patel V, Ogg GS, (2012) Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. Clin Exp Dermatol 37: 534-543. doi:10.1111/j.1365-2230.2012.04305.x. PubMed: 22639919.
65. Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, et al. (2006) Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 177: 8658-8666. PubMed: 17142766.
66. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A, (2009) Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83: 440-453. doi:10.1128/JVI.01864-08. PubMed: 18971266.